tradingkey.logo

iSpecimen Inc

ISPC
查看詳細走勢圖
0.388USD
+0.007+1.89%
收盤 12/24, 13:00美東報價延遲15分鐘
3.79M總市值
虧損本益比TTM

iSpecimen Inc

0.388
+0.007+1.89%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.89%

5天

-0.03%

1月

-19.92%

6月

-57.18%

今年開始到現在

-85.40%

1年

-86.16%

查看詳細走勢圖

TradingKey iSpecimen Inc股票評分

單位: USD 更新時間: 2025-12-24

操作建議

iSpecimen Inc當前公司基本面數據相對健康,增長潛力穩定。當前估值合理,在軟體與IT服務行業排名278/482位。機構持股佔比非常高,中期看,股價處於下降通道。近一個月,市場表現非常差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

iSpecimen Inc評分

相關信息

行業排名
278 / 482
全市場排名
524 / 4562
所屬行業
軟體與IT服務

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

iSpecimen Inc亮點

亮點風險
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
業績增長期
公司處於發展階段,最新年度總收入9.29M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入9.29M美元
估值高估
公司最新PE估值-0.05,處於3年歷史高位
機構減倉
最新機構持股96.86K股,環比減少10.31%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉29.41K股

iSpecimen Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

iSpecimen Inc簡介

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
公司代碼ISPC
公司iSpecimen Inc
CEOField (Katharyn)
網址https://www.ispecimen.com/

常見問題

iSpecimen Inc(ISPC)的當前股價是多少?

iSpecimen Inc(ISPC)的當前股價是 0.388。

iSpecimen Inc 的股票代碼是什麼?

iSpecimen Inc的股票代碼是ISPC。

iSpecimen Inc股票的52週最高點是多少?

iSpecimen Inc股票的52週最高點是3.380。

iSpecimen Inc股票的52週最低點是多少?

iSpecimen Inc股票的52週最低點是0.360。

iSpecimen Inc的市值是多少?

iSpecimen Inc的市值是3.79M。

iSpecimen Inc的淨利潤是多少?

iSpecimen Inc的淨利潤為-12.50M。

現在iSpecimen Inc(ISPC)的股票是買入、持有還是賣出?

根據分析師評級,iSpecimen Inc(ISPC)的總體評級為--,目標價格為--。

iSpecimen Inc(ISPC)股票的每股收益(EPS TTM)是多少

iSpecimen Inc(ISPC)股票的每股收益(EPS TTM)是-7.816。
KeyAI